TINA YOUNG: Open Payments
NPI 1750322921 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 64 payments from 20 companies in 2025. Trend: 2023 $964 · 2024 $1,223 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $165 |
| Lilly USA, LLC | 9 | $153 |
| Exact Sciences Corporation | 5 | $101 |
| ABBVIE INC. | 5 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Novo Nordisk Inc | 5 | $82 |
| Astellas Pharma US Inc | 4 | $80 |
| Amgen Inc. | 5 | $77 |
| Gilead Sciences, Inc. | 3 | $73 |
| GlaxoSmithKline, LLC. | 3 | $55 |
Products named: MOUNJARO, Kerendia, BREZTRI, FARXIGA, Veozah, Cologuard Collection Kit, OTEZLA, REXULTI.
Industry payments across CA — which companies pay providers there.
